Phase II trial of mitoxantrone.
D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced; D000880:Anthraquinones / Q000008:administration & dosage / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006321:Heart / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone; D009369:Neoplasms / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced
D000880:Anthraquinones; D000970:Antineoplastic Agents; D008942:Mitoxantrone